) for a scientific commentary on this article.
Introduction
REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of normal skeletal muscle atonia during paradoxical sleep (also coined REM sleep) favouring dream-enacting behaviours, without major modification of paradoxical sleep quantities (Schenck et al., 1986) . Recently RBD has been considered as a prodromal biomarker of synucleinopathies such as Parkinson's disease or multiplesystem atrophy, resulting from pathological brain deposition of native -synuclein protein (Iranzo et al., 2013) . Indeed, most patients (%80%) diagnosed for RBD eventually develop one such synucleinopathy within 10-15 years (Iranzo, 2005; Postuma et al., 2009; Iranzo et al., 2013; Schenck, 2013) . Neuroimaging and post-mortem studies recently observed damage or presence of Lewy bodies within the dorsal pontine tegmentum in patients with RBD and comorbid Parkinson's disease (Schenck et al., 1996; Scherfler et al., 2005; Tippmann-Peikert et al., 2006; Mathis et al., 2007; Boeve, 2013; Garcia-Lorenzo et al., 2013; Iranzo et al., 2013; Peever et al., 2014) . These data in humans suggest that loss of neurons in this area may be the primary cause of RBD pathogenesis. In fact, a small nucleus within the dorsal pons named sublaterodorsal tegmental nucleus (SLD, also coined subcoeruleus nucleus in humans and peri-locus coeruleus alpha in cats), seems crucial for muscle atonia during paradoxical sleep (Fort et al., 2009; Luppi et al., 2011; Peever et al., 2014) . Electrolytic or neurochemical lesion of SLD area induces in cats, rats and mice loss of muscle atonia, appearance of abnormal motor behaviours (muscle jerks of extremities, abrupt movements) and a reduction of paradoxical sleep amounts (Roussel et al., 1976; Sastre and Jouvet, 1979; Lu et al., 2006) . Conversely, pharmacological activation of SLD neurons induces a paradoxical sleep-like state in cats (VanniMercier et al., 1989; Sakai et al., 2001) and rats (Boissard et al., 2002) . Furthermore, the SLD contains neurons with a tonic firing activity highly specific to paradoxical sleep sending either ascending (to thalamus) or descending (to lower brainstem/spinal cord) projections (Sakai and Koyama, 1996; Boissard et al., 2002; Sakai, 2015) and numerous c-Fos-labelled (c-Fos + ) neurons after experimentally induced paradoxical sleep hypersomnia (Verret et al., 2006; Sapin et al., 2009; Clement et al., 2011; Arthaud et al., 2015) . A vast majority (%84%) of these neurons are glutamate as expressing the neuronal vesicular glutamate transporter 2 (vGluT2, encoded by SLC17A6; Clement et al., 2011). We propose that entry in paradoxical sleep, marked by a synchronized cortical activation and muscle atonia, results from the strong activation of glutamate paradoxical sleep-on neurons circumscribed to the SLD . To further examine the specific role in paradoxical sleep of the glutamate SLD neurons in the rat, we first determined anatomically whether they provide projections both ascending (to the intralaminar thalamus) and descending (to the ventral gigantocellular reticular nucleus), the two main SLD targets (Boissard et al., 2002) . Then, we quantified the physiological effect on paradoxical sleep of bilateral infusion of adeno-associated viral vectors (AAVs) carrying short hairpin (sh)RNAs against Slc17a6 (termed AAV-shvGluT2) to chronically inactivate glutamate neurotransmission from SLD neurons (Thakker et al., 2006; Lazarus et al., 2011) . Combining molecular tools to innovative behavioural analysis methods, we demonstrate that selective glutamate transmission impairment in SLD is sufficient to mimic in healthy rats the major pathological symptoms of human RBD, i.e. a tremendous increase of abnormal motor behaviours, a nearly total loss of muscle atonia during paradoxical sleep with a limited decrease in paradoxical sleep quantities, explained by anatomical connections with inhibitory neurons in the ventral medulla. These original data unravel that glutamate SLD neurons generate the muscle atonia during paradoxical sleep but not the state of paradoxical sleep itself. Further, they validate a reproducible preclinical RBD model in rodents that may provide new experimental opportunities for clinical research to improve RBD treatments and thus patient's healthcare.
Materials and methods
Sprague Dawley male rats (Charles River Laboratories) were housed individually in recording Plexiglas Õ barrels (30 cm diameter, 40 cm height) under 12-h light/dark cycle (08:00 am/pm). Room temperature was maintained at 21 AE 1 C. Food pellets (A04 SAFE, Extra Labo) and water were available ad libitum.
intraperitoneally; Virbac) and mounted in a stereotaxic frame (David Kopf Instruments) . Two holes were drilled in the skull above the right gigantocellular reticular nucleus and intralaminar thalamus. A borosilicate glass micropipette (7-10 mm tip diameter) backfilled with low-salt cholera toxin b subunit (CTb; 0.5%; List Biological Laboratories; Luppi et al., 1990) was lowered with hydraulic micropositioner (David Kopf Instruments) into the gigantocellular reticular nucleus [anterior-posterior (AP), À13.5 mm from Bregma; medial-lateral (ML), + 1 mm; dorsal-ventral (DV), À8.5 mm below brain surface, 7 posterior angle; (Paxinos and Watson, 1998) ]. The micropipette was connected by a silver wire to a current generator (CS4, Transkinetics) delivering a pulsed current ( + 1 mA, 7 s on/off) for 15 min. Similarly, a second micropipette backfilled with FluoroGold Õ (FG, 1%; Sigma-Aldrich) was lowered into intralaminar thalamus (AP, + 3.7 mm from Bregma; ML, 0.8 mm; DV, 5 mm, 7 posterior angle) where FG was ejected using a constant current ( + 1 mA) for 15 min.
Stereotaxic injections of viral vectors
Young rats (240-260 g) were prepared in the same way for bilateral injections of viral vectors in SLD (AP, À10.9 mm to Bregma; ML, 1.2 mm; DV, 6.1 mm, 15 posterior angle). AAVshvGluT2-mCherry and AAV-shCTRL-mCherry were injected with a cannula (33 gauge; PlasticsOne) connected by a polyethylene tubing (PlasticsOne) to a 10 ml Hamilton syringe placed into an UltraMicroPump (UMP3 with SYS-Micro4 controller, WPI). Each SLD received a volume of 300 nl delivered at 40 nl/min.
Surgical preparation for polysomnography
Once the injection procedure was completed, rats were implanted for polysomnographic recordings of cortical EEG and nuchal EMG (Verret et al., 2005; Sapin et al., 2009; Clément et al., 2014; Renouard et al., 2015) . Briefly, four stainless-steel screws (PlasticsOne) were screwed to the skull over the frontal (AP, + 3 mm to Bregma; ML, 1 mm), parietal (AP, À4 mm; ML, + 3 mm), occipital (AP, À8 mm; ML, + 3 mm) and cerebellar cortices (AP, À12 mm; ML, + 3 mm; reference electrode). Two gold-coated electrodes were inserted in between neck muscles for differential EMG recording. Electrode leads were connected to a miniature plug (PlasticsOne) and fixed to the skull using acrylic Superbond (Sun Medical Co) and dental Paladur Õ cement (Heraeus Kuzler).
Generation of viral vectors
For the generation of AAV-shRNA-mCherry vector plasmids, a H1-shRNA-Ctrl cassette was amplified by polymerase chain reaction (PCR) from the pSilencer 3.1-H1 neoplasmid (Applied Biosystems, Life Tech) containing the control shRNA sequence (GTCAGGCTATCGCGTATCG; Ambion kit, Life Tech). This cassette was then inserted into the MluI site of the psiSTRIKEhMGFP plasmid (Stratagene, Life Tech). Subsequently, the hrGFP gene was replaced by the mCherry encoding one. The sequence shCTRL was then removed via BamHI and HindIII and replaced by shRNA-vGluT2 sequence (TGAAACCAGAG ATAGCAAATC).
The AAVs of serotype rh10 were generated by tripartite transduction (AAV-rep2/caprh10 expression plasmid, adenovirus helper plasmid, and AAV-vector plasmid) into 293A cells. After 3 days, 293A cells were resuspended in artificial CSF, freeze-thawed four times and treated with benzonase nuclease (EMD Millipore) to degrade all forms of DNA and RNA. Subsequently, cell debris was removed by centrifugation and the virus titre in the supernatant was determined with quantitative PCR (AAV-shCTRL-mcherry, 4.5 Â 10 12 particles/ml and AAV-shvGluT2-mcherry, 5.6 Â 10 12 particles/ ml).
Polysomnographic recordings
After 5-7 days to recover from surgery, rats were connected to a cable plugged to a rotating connector (PlasticsOne) allowing free movements. After 3 days of habituation, vigilance states were continuously recorded until the completion of experiments. EEG and EMG signals were amplified (MCP + , Alpha-Omega Engineering), analogue-to-digital converted with a sampling rate of 520.8 Hz and collected on a PC via a CED-1401 Plus interface with Spike2 software (CED). Polysomnographic recordings were synchronized to videos using digital black/white cameras (GigEPoE, Elvitec) managed by Streampix 6 software (NorPix).
Paradoxical sleep deprivation and recovery
Rats dedicated to tract-tracing studies were submitted before sacrifice to a selective paradoxical sleep deprivation with the standard flowerpot method (Maloney et al., 1999; Verret et al., 2005; Lu et al., 2006; Sapin et al., 2009; Clement et al., 2011) . Two experimental groups were made: (i) paradoxical sleep-deprived rats placed at 12:00 am for 75 h in a Plexiglas Õ barrel containing three platforms (6.5 cm in diameter) surrounded by water (2 cm); and (ii) paradoxical sleep hypersomniac rats submitted to the same protocol during 72-h and allowed to recover (paradoxical sleep rebound) in a barrel with a dry bed of woodchips. They were sacrificed 2 h after the first paradoxical sleep episode. During deprivation, food and water were available ad libitum and barrels were cleaned daily.
Histological procedures
Rats treated with viral vectors were sacrificed at Day 30 postsurgery and rats with retrograde tracers at Day 10-12 postinjection.
Preparation of brainstem sections
Under lethal anaesthesia with pentobarbital (150 mg/kg, intraperitoneally, Ceva Santé Animale), rats were transcardially perfused first with Ringer's lactate solution containing 0.1% heparin, followed by 500 ml of a cold fixative solution composed of 4% freshly depolymerized paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4. The brains were removed, placed overnight at 4 C in the same fixative and for 3 days in sterile 30% sucrose solution. Brains were then rapidly frozen in cooled methyl-butane and cut with a cryostat in serial coronal sections (25-mm thick for the tract-tracing studies and 30-mm thick for in situ hybridization). Serial freefloating sections were collected in RNase free cryoprotectant solution and stored at À20 C until use (Sapin et al., 2009; Clement et al., 2011). c-Fos/CTb, c-Fos/FG and CTb/FG double immunostaining Free-floating sections were successively incubated in (i) a rabbit antiserum against c-Fos (1:10 000, Merck Millipore) or goat antiserum against CTb (1:80 000; List Biological Labs) in PBST-Az [phosphate-buffered saline (PBS) containing 0.3% Triton TM X-100 and 0.1% sodium azide] for 3 days at 4 C; (ii) biotinylated horse anti-rabbit or anti-goat IgG (1:1000 in PBST, Vector Labs) for c-Fos or CTb staining, respectively; and (iii) ABC-HRP solution (1:1000; Vectastain Elite kit, Vector Labs) for 90 min at room temperature. Finally, the staining was revealed in a 0.05 M Tris-HCl buffer, pH7.6, containing 0.25% 3,3 0 -diaminobenzidine-4HCl (DAB; SigmaAldrich), 0.03% H 2 O 2 and 0.6% nickel ammonium sulphate. After extensive washes, the c-Fos immunostained sections were incubated in a rabbit antiserum against FG (1:20 000, SigmaAldrich); (ii) or a goat antiserum against CTb (1:80 000) in PBST-Az over 3 days at 4 C. Alongside, the CTb immunostained sections were incubated in a rabbit antiserum against FG (1:20 000) over 3 days at 4 C. Amplification steps were similar to those described above, except that the histochemical revelation was performed in DAB solution without nickel ammonium sulphate. In rats with a tracer injection in intralaminar thalamus, pontine sections were double immunostained for FG and choline acetyltransferase, a cholinergic marker (goat anti-ChAT, 1:5000; Chemicon). Finally, sections were mounted on glass slides, dried and coverslipped with Depex mounting medium.
In situ hybridization of Slc17a6/vGluT2 mRNA Antisense and sense digoxigenin-labelled probes against Slc17a6/vGluT2 were synthesized from a recombinant linearized plasmid containing the Slc17a6/vGluT2 cDNA using a non-radioactive RNA labelling kit (Roche Diagnostic; Clement et al., 2011) . All buffers contained 0.2% of RNase inhibitor (ProtectRNA TM , Sigma-Aldrich). Free-floating sections were firstly rinsed in PBST containing 10 mM dithiothreitol (DTT, Sigma-Aldrich) and a standard saline citrate solution (SSC 2Â). They were then placed overnight at 65 C in the hybridization buffer containing 0.5 mg/ml of the digoxigeninlabelled probe. Sections were washed in SSC, 50% formamide, 0.1% Tween 20, treated with RNase A (USB Corporation) and finally incubated in a solution of anti-digoxigenin IgG conjugated to alkaline phosphatase (1:2000, Roche Diagnostic). Staining was revealed using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (Roche Diagnostic). Finally, the sections were mounted on slides and coverslipped with VectaMount TM (Vector Labs). Controls in absence of antidigoxigenin or with the sense probe were run to ensure for the labelling specificity.
mCherry immunohistochemistry and in situ hybridization for Slc6a5/GlyT2 mRNA This protocol was designed to determine whether axons emanating from transducted SLD neurons contact ventral medullary glycine neurons. The antisense and sense digoxigeninlabelled probes against mRNA for Slc6a5 (which encodes neuronal glycine transporter 2, GlyT2) were synthesized by reverse transcription from brainstem tRNA to obtain cDNA. This cDNA containing Slc6a5/GlyT2 sequence was linearized using a non-radioactive RNA labelling kit (Roche Diagnostic). The brain sections from AAV-treated rats were successively incubated overnight with a rat antiserum against mCherry (1:100 000 in PBST at 4 C, ThermoFisher Scientific), 90 min in biotinylated rabbit anti-rat IgG and in ABC-HRP (1:1000 in PBST; Vector Labs). Then, the sections were revealed for 15 min in a Tris-HCl containing 0.025% DAB and 0.003% H 2 O 2 . All buffers used contained 0.2% of RNase inhibitor (ProtectRNA, Sigma-Aldrich). Immunostained sections were then treated in the same way as for Slc6a5/GlyT2 probe. Controls of specificity were done by omitting the primary antibodies or by using the sense probe.
Double mCherry/vGluT2 immunofluorescence
Free-floating sections were incubated for 3 days at 4 C in PBST-Az containing both rabbit IgG against vGluT2 (1:500, Synaptic Systems) and rat IgG against mCherry (1:50 000, ThermoFisher Scientific). After rinses, they were incubated for 24 h in PBST containing a mixture of secondary donkey antibodies tagged with Alexa Fluor Õ 488 and 594 (anti-rabbit and anti-rat, respectively, 1:500, ThermoFisher Scientific). After rinses in PBST, sections were finally mounted on slides, coverslipped with Fluoromount TM (Vector Labs) and immediately analysed to prevent fluorescence fading. Digital images were scanned and recorded using a TCS-Sp5X confocal fluorescence microscope (Leica) at a resolution of 1024 Â 1024 pixels/frame with an objective 63 Â (zoom 3, 0.5 mm image thickness).
Analysis of polysomnographic data Sleep quantification
Vigilance states were scored by 5-s epochs and classified as waking, slow-wave sleep and paradoxical sleep based on the visual inspection of EEG/EMG signals. During waking, activated low-amplitude EEG is accompanied by a sustained EMG activity with phasic bursts. Slow-wave sleep is characterized by high voltage EEG slow waves, spindles and the disappearance of phasic muscle activity. A decrease in the EEG amplitude associated with a flat EMG (muscle atonia) and a regular and pronounced theta rhythm (theta band activity, 4-8 Hz) indicates the onset of paradoxical sleep. Hypnograms were then drawn directly using a custom script in Spike2 (CED). The values were finally exported to calculate standard parameters for each vigilance state [quantities, percentage, number and bout duration expressed as mean AE standard error of the mean (SEM)].
EMG quantification
The muscle atonia is defined as a drastic and sustained reduction of muscle tone during paradoxical sleep compared to the preceding slow-wave sleep. We computed nuchal EMG signals to extract mean muscle tone values for each paradoxical sleep episode and the preceding slow-wave sleep bout. Only paradoxical sleep episodes longer than 45 s were considered, eliminating first and last 5 s of each bout to avoid transition states (slow-wave sleep-paradoxical sleep and paradoxical sleepwaking). Then a mean value of EMG during paradoxical sleep and slow-wave sleep was obtained based on all considered episodes. This was done for each rat of both experimental groups over the 12-h light period of Day 30 postsurgery. To better illustrate installation or not of muscle atonia between slow-wave sleep and paradoxical sleep in both groups, we calculated the ratio EMG during slow-wave sleep versus EMG during paradoxical sleep.
Actimetry
Nuchal EMG does not reflect motor activity of distal extremities (limbs, ears, whiskers). We thus developed a MatLab routine to quantify whole body movements during consolidated paradoxical sleep episodes based on off-line videos synchronized to EEG/EMG recordings. This was done for each AAV-treated rat at Day 30 post-surgery during the 12-h light period. The so-called actimetric value represents the number of pixels with modified grey value between two successive video frames (20 ms interval) due to rat's movements. Finally, mean actimetric value was calculated for each paradoxical sleep episode for each animal as the mean pixels number modified per second during 12 h. To further estimate amounts of paradoxical sleep motor events, we defined in shCTRL rats the threshold as 99.5th percentile of mean actimetry value of consolidated paradoxical sleep bouts and then applied this threshold to paradoxical sleep episodes of shvGluT2 rats. In this way, we were able to calculate the number of motor events (defined as the pixels increase above the threshold and lasting 4 50 ms) and the percentage of paradoxical sleep time that animals spend moving and twitching.
Spectral analysis
A fast Fourier transform (FFT) analysis of parietal EEG was computed using a Spike-2 script in shvGluT2 versus shCTRL rats across the 12-h light period on Day 30 post-surgery. All epochs with artefacts were excluded from the analysis. For each 5-s epoch, a power spectrum was calculated (bin size 0.2 Hz, 0-30 Hz). Then, a mean spectrum was generated for each vigilance state with standard frequency ranges of EEG rhythms (delta, 0.5-4.6 Hz; theta, 5.1-8.9 Hz; sigma, 9.9-14 Hz; beta, 15-30 Hz).
Quantitative analysis of CTb/FG, c-Fos/CTb and c-Fos/FG doublelabelled neurons
We mapped singly labelled c-Fos (c-Fos + ), CTb (CTb + ) and FG (FG + ) neurons and double-labelled CTb + /FG + , c-Fos + / CTb + and c-Fos + /FG + neurons in eight rats (four paradoxical sleep-deprived rats and four paradoxical sleep hypersomniac rats) with CTb and FG injection sites in the gigantocellular reticular nucleus and intralaminar thalamus of the same hemisphere. This analysis was focused on the dorsal pons, bilaterally from levels AP À8 to À9.4 mm to Bregma (Paxinos and Watson, 1998) . Double-labelled sections taken every 200 mm were drawn and labelled cells plotted using an Axioskop microscope (Zeiss) equipped with a motorized x-ysensitive stage and a colour video camera connected to a computerized image analysis system (Mercator; ExploraNova). Cells of each type (singly or double-labelled) were counted for each pontine area and exported using Mercator. When an area was present on several sections, neurons counted were summed.
Statistics
Because of the reduced number of animals used (3R principles in animal experiments), non-parametric statistical tests were used. For the comparison of vigilance states and numbers of labelled neurons across paradoxical sleepdeprived rats and paradoxical sleep hypersomniac rats conditions, Mann-Whitney U-test was used to identify pairwise differences. The effect of paradoxical sleep deprivation and recovery versus the baseline was analysed with a Wilcoxon signed rank test. Statistical differences in state quantities, duration, number and mean duration of episodes, spectral analysis, EMG quantification and actimetry in shCTRL versus shvGluT2 rats were also determined with a MannWhitney U-test. All statistics were performed using StatView software and a significant effect was considered when P 5 0.05.
Animal studies approval
All experiments were conducted in application of the 3R principles in animal experiments and in accordance to the European Community Council Directive for the use of research animals (86/609/EEC; http://ec.europa.eu/food/fs/aw/aw_legis lation/scientific/86-609-eec_en.pdf and 2010/63/EU; http://ec. europa.eu/environment/chemicals/lab_animals/pdf/endorsed_ awb-nc.pdf). Protocols and procedures used were approved by the local Comité d'Ethique en Experimentation Animale of Lyon I University (C2EA-55, UCBL) and the French Ministère de l'Enseignement Supérieur et de la Recherche (Authorization number DR-2014-37).
Results
Are glutamate sublaterodorsal tegmental nucleus neurons in position to generate paradoxical sleep?
We hypothesized that paradoxical sleep (PS)-on (higher activity during paradoxical sleep) SLD neurons induce cortical activation via their projections to the intralaminar thalamus and muscle atonia by collaterals to ventral gigantocellular reticular nucleus (Boissard et al., 2002; Luppi et al., 2011) . We first assessed whether the SLD contains CTb/FG double-labelled neurons after injections of CTb and FG retrograde tracers, respectively, in the right gigantocellular reticular nucleus and intralaminar thalamus (n = 4 rats, Fig. 1A ). As illustrated in Fig. 1B , FG injections (400-500 mm in diameter) encroached both the central medial and mediodorsal intralaminar thalamus while CTb injection sites restricted to the gigantocellular reticular nucleus were smaller in diameter (200-250 mm; Fig. 1C ). The analysis revealed an overlapped distribution of CTb + and FG + cell bodies within the dorsal pons. Indeed, numerous FG + neurons were found with an ipsilateral predominance in the laterodorsal tegmental nucleus and to a lesser degree the SLD and the dorsomedial tegmental area just ventral to it. Conversely, CTb + cells were more abundant in ipsilateral SLD and dorsomedial tegmental area than in laterodorsal tegmental nucleus (Fig. 1D, D' and Table 1) . Despite the overlapping distribution of CTb + and FG + neurons, double-labelled cells were never observed within the SLD, laterodorsal tegmental nucleus and dorsomedial tegmental area (Fig. 1D and D' ) or in other brain areas (not shown). These anatomical data reveal that SLD ascending and descending projections emanate from two distinct intermingled cell subpopulations and not a single one as anticipated.
To determine if these pathways are activated during paradoxical sleep, rats with an injection of CTb into the gigantocellular reticular nucleus (n = 8; Fig. 1B ) or FG into Percentage of double-labelled (single CTb + or single FG + ) neurons within SLD and neighbouring pontine areas for each experimental condition (paradoxical sleep-deprived rats, n = 4; paradoxical sleep hypersomniac rats, n = 4). Percentages calculated for SLD, laterodorsal tegmental nucleus and dorsomedial tegmental area are significantly higher in paradoxical sleep hypersomniac rats compared to paradoxical sleep-deprived rats. LDTg = laterodorsal tegmental nucleus; LPB = lateral parabrachial nucleus; MPB = medial parabrachial nucleus.
the intralaminar thalamus (n = 8, Fig. 1A ) were submitted to the flowerpot method of paradoxical sleep deprivation. Half of the animals sacrificed after 72-h of paradoxical sleep deprivation (the paradoxical sleep-deprived rats group) spent 3.8 AE 1.3% of their time in paradoxical sleep (versus 14.5 AE 1.5% in baseline) during the last 2 h before sacrifice. The remaining rats (the paradoxical sleep hypersomniac rats group) were allowed to recover for 2 h during which they displayed 35.3 AE 3.9% of paradoxical sleep (versus 15.8 AE 1.2% at baseline; Supplementary Table 1 ). In line with our previous studies, significantly higher numbers of c-Fos + neurons were found in the laterodorsal tegmental nucleus, dorsomedial tegmental area and SLD in paradoxical sleep hypersomniac versus paradoxical sleep-deprived rats (Fig. 1E and F) . A significantly higher number of c-Fos + /CTb + neurons populated these structures in paradoxical sleep hypersomniac versus paradoxical sleep-deprived rats (Mann-Whitney U-test, Z = À2.165, P = 0.03; Z = À2.304, P = 0.02, respectively; Fig. 1G and Table 1 ). Within the SLD, the number of c-Fos + /CTb + neurons was of 17 AE 4.5 in paradoxical sleep hypersomniac rats rats (42% of CTb + neurons) versus 4.3 AE 1.7 (10.5% of CTb + neurons) in paradoxical sleep-deprived rats rats (Fig. 1F, F ', H and Table 1 ) (Mann-Whitney U-test, Z = À2 021, P = 0.04). By comparison, 22% and 16% of the CTb + cells within laterodorsal tegmental nucleus (1.8 AE 0.5) and dorsomedial tegmental area (4.8 AE 2.3) were c-Fos + in paradoxical sleep hypersomniac rats. In sharp contrast, after injection of FG into the intralaminar thalamus, c-Fos + /FG + neurons were rarely counted in the Mean numbers (mean AE SEM) of single FG + , single CTb + , double-labelled c-Fos + /FG + and double-labelled c-Fos + /CTb + neurons counted in the ipsilateral and contralateral SLD and neighbouring nuclei in paradoxical sleep-deprived rats (n = 4) and paradoxical sleep hypersomniac rats (n = 4) rats. For each rat and each pontine nucleus considered, sums of labelled neurons were calculated on five consecutive sections (200 mm interval) and then averaged for each rat's sample. The percentages displayed correspond to the ratio doubleversus single-labelled neurons with each given marker of interest. For comparison between paradoxical sleep-deprived rats and paradoxical sleep hypersomniac rats condition, significance values after non-parametric unpaired Mann-Whitney U-test are given by * P 5 0.05. DMTg = dorsomedial tegmental area; LDTg = laterodorsal tegmental nucleus; LPB = lateral parabrachial nucleus; MPB = medial parabrachial nucleus; PSD = paradoxical sleep deprivation; PSR = paradoxical sleep rebound.
laterodorsal tegmental nucleus, dorsomedial tegmental area and SLD both in paradoxical sleep-deprived and hypersomniac rats (Fig. 1E , E' and Table 1 ). The lateral parabrachial nucleus (LPB) was the only structure in which the number of c-Fos + /FG + neurons was different in paradoxical sleepdeprived versus paradoxical sleep hypersomniac rats (6.9 AE 2 versus 0.8 AE 0.4 of double-labelled neurons; 10.5 AE 3.7% versus 0.5 AE 0.2%; Mann-Whitney U-test, Z = À2.309, P = 0.02) (Fig. 1G, H and Table 1 ). Further, we quantified that 23.6 AE 4.3% of FG + neurons in SLD were immunopositive for ChAT (n = 6 rats). In conclusion, the functional heterogeneity of SLD neurons is not in favour of a single population of SLD neurons responsible for the synchronized induction of muscle atonia and EEG activation during paradoxical sleep, but more in position to generate muscle atonia during paradoxical sleep through excitatory descending inputs.
shRNA-vGluT2 suppresses glutamate signalling in the sublaterodorsal tegmental nucleus
To block synaptic glutamate release in SLD neurons, we performed local and bilateral injections of AAVshvGluT2-mCherry (versus AAV-shCTRL-mCherry). Numerous SLD cell bodies were strongly fluorescent for mCherry ( Fig. 2A-C ) in injection loci in both experimental (n = 5) and control (n = 5) rats. We then assessed by in situ hybridization the expression/absence of Slc17a6/vGluT2 mRNA within AAV injection sites at Day 30 post-injection. In AAV-shCTRL rats, there were a large number of neurons expressing Slc17a6/vGluT2 mRNA (vGluT2 + ; Fig. 2B ; Clement et al., 2011) within the injection loci. In AAV-shvGluT2, no vGluT2 + neurons were longer visible within the injection sites, highly contrasting with surrounding regions unaffected by AAVs spreading (Fig. 2D) . Such total suppression of Slc17a6/vGluT2 mRNA expression was already achieved at Day 10 post-infusion (not shown) and no recovery was noticed at Day 30 post-treatment (Fig. 2C-D' ). To control that native vGluT2 protein was indeed absent from the transducted glutamate SLD neurons, we examined by confocal microscopy in control and experimental rats the co-localization of vGluT2 and mCherry in axon terminals in ventral medulla including raphe magnus, alpha gigantocellular reticular nucleus and gigantocellular reticular nucleus. In control rats, a high number of mCherry-labelled fibres and terminals (red) were also stained for vGluT2 (green) and thus appeared yellow coloured on merge photomicrographs (Fig. 2E and  F) . In AAV-shvGluT2 animals, a dense plexus of mCherrylabelled fibres was also observed in raphe magnus, alpha gigantocellular reticular nucleus and gigantocellular reticular nucleus but no yellow labelling was detected on merged photomicrographs (Fig. 2F) , indicating that the expression of vGluT2 is suppressed in transducted glutamate SLD neurons in AAV-shvGluT2 rats. By coupling the immunodetection of mCherry to the in situ hybridization for Slc6a5/ GlyT2 mRNA, we observed plexuses of mCherry-labelled fibres closely apposed on GlyT2 + neurons in raphe magnus, alpha gigantocellular reticular nucleus and gigantocellular reticular nucleus ( Fig. 2G and H) . Taken together, our data indicate that glutamate release of SLD neurons in their synaptic terminals in proximity of GABA/glycine neurons within the ventral medulla is chronically prevented in AAV-shvGluT2 rats.
Glutamate sublaterodorsal tegmental nucleus neurons are not necessary for paradoxical sleep generation
To study the role of glutamate SLD neurons in paradoxical sleep, we compared the sleep-waking cycle of AAVshvGluT2 and AAV-shCTRL rats at Day 30 post-treatment. As shown in Fig. 2A -C, injection sites (5800 mm in diameter) embraced the whole SLD, only slightly encroaching adjacent pontine areas such as the ventral part of laterodorsal tegmental nucleus or the dorsomedial tegmental area. Only treated rats depicting bilateral AAVs injections centred and covering the whole SLD were included in this study (n = 5 rats in each group; Fig. 3A) .
Daily paradoxical sleep quantities were significantly reduced (À33%) in experimental versus control rats (7.3 AE 1.7 versus 10.9 AE 0.6% of total time; MannWhitney U-test, Z = À2.008, P = 0.04; Fig. 3B ). The decrease was due to a non-significant reduction of both the number (99.4 AE 23.7 versus 108.8 AE 16.2, P = 0.60) and duration of paradoxical sleep bouts (1.0 AE 0.1 versus 1.6 AE 0.6 min, P = 0.07, Supplementary Table 2 ). Daily slow-wave sleep amounts showed a tendency to decrease in experimental rats (39.7 AE 2.9 versus 33.4 AE 3.2%; P = 0.23) counterbalanced by a non-significant increase of daily waking amounts (49.4 AE 2.9 versus 59.3 AE 4.7%; P = 0.068; Fig. 3B and Supplementary Table 2) . No significant difference in EEG power spectrum was evidenced during paradoxical sleep between the two groups (Fig. 3C) . In summary, genetic inactivation of glutamate SLD neurons induces a limited decrease of paradoxical sleep quantities, not supporting the consensual hypothesis that these neurons are responsible for paradoxical sleep generation. This is in line with our preceding neuroanatomical and functional data that glutamate PS-on SLD neurons do not send ascending projections and are hence not in a suitable position for synchronizing the generation of paradoxical sleep per se.
Glutamate sublaterodorsal tegmental nucleus neurons are responsible for muscle atonia during paradoxical sleep
As shown by nuchal EMG recordings in AAV-shCTRL rats (Fig. 3D) , muscle atonia is defined as a sustained decrease of the muscle tone during paradoxical sleep compared to the preceding slow-wave sleep episode. This contrasts with EMG recordings in AAV-shvGluT2 rats showing alternating periods of high to low muscle tone along paradoxical sleep episodes and an increase of excessive, abnormal and sporadic motor activities ( Fig. 3E and F) . To compare muscle tone, we calculated at Day 30 the mean amplitude of the EMG signal during paradoxical sleep and prior slowwave sleep episodes. In AAV-shCTRL rats, a significant decrease of absolute EMG values was observed during paradoxical sleep compared to slow-wave sleep (8.6 AE 0.9 versus 9.7 AE 0.9 respectively; Wilcoxon test, P = 0.04) resulting in a mean paradoxical sleep versus slow-wave sleep ratio of 0.91, indicative for a lower nuchal muscle tone during paradoxical sleep than during slow-wave sleep ( Fig. 3G and H) . In contrast, AAV-shvGluT2 rats did not show significant difference of absolute EMG values during paradoxical sleep and prior slow-wave sleep (12.6 AE 1.6 versus 11.6 AE 2.0; Wilcoxon test, P = 0.14). Further, the mean ratio value was slightly superior to 1 (1.03) and significantly higher in experimental versus control rats (Mann-Whitney U-test, Z = À2.739, P = 0.02; Fig. 3F and G). Indeed, no difference in absolute EMG values was observed during slow-wave sleep between the two groups of rats (Mann-Whitney U-test, Z = À 1.149, P = 0.25, Fig. 1G ), or in the duration of phasic bursts (0.81 AE 0.13 in experimental versus 0.61 AE 0.09 s in control rats; MannWhitney U-test Z-value = À1.149; P = 0.2506).
Nevertheless, nuchal EMG recordings do not reflect the occurrence of remarkable phasic motor events during paradoxical sleep in AAV-shvGluT2 rats at the level of extremities such as limbs, tail or face (Fig. 3D-F and Supplementary Videos 1-3). We objectively quantified abnormal oneiric, RBD-like behaviours by off-line 'actimetry' analysis of videos time-locked to polysomnography ( Fig. 4A and B) . We found out that the mean actimetry index (corresponding to the mean number of video pixels modified every second of paradoxical sleep) significantly increased in AAV-shvGluT2 versus AAV-shCTRL rats (Mann-Whitney U-test, Z = À2.449, P = 0.01; Fig. 4C ). More precisely, both the number of motor events (5.6 AE 1.4 versus 1.0 AE 0.2; Mann-Whitney U-test, Z = À2.449, P = 0.01) and the percentage of paradoxical sleep with movements (3.7 AE 1.6 versus 0.3 AE 0.1%; Mann-Whitney U-test, Z = À2.449, P = 0.01) significantly increased in experimental versus control rats ( Fig. 4D and  E) . The careful observation of EMG signals and videos revealed a great variability in intensity and frequency of abnormal motor events among paradoxical sleep episodes in each experimental rat and within AAV-shvGluT2 group ( Fig. 3G and H) . Such variability between individuals has been reported in RBD patients (Oudiette et al., 2009; Iranzo et al., 2016) . It is unlikely that it is due to a difference in the number or location of the glutamate SLD neurons inactivated as AAV injection sites included in this work are similar between rats. Rather, it could be due to stronger movements in some of them associated with more intense and vivid oneiric activities. Qualitatively, motor enactments during paradoxical sleep correspond to assorted non-elaborated behaviours that are loosely arranged at the level of the head, fore and hind limbs (Supplementary Video 2), tail or nose, rarely synchronized over multiple body territories. Occasional more complex movements were observed like seeking for food with the snout in woodchips, eating a virtual pellet, trying to run or jump (Supplementary Video 3). During these oneiric-like motor behaviours, experimental rats kept their eyes closed, indicating they are asleep. Vocalizations were not obvious in experimental rats. However, whether they emit ultrasonic vocalizations during paradoxical sleep remains to be studied using specific microphones. Experimental rats depicted normal locomotor activity and feeding behaviour during waking (with a standard weight increase) and did not display dream enactments during slow-wave sleep, seizures or modification of their body aspect.
Discussion
This work noticeably expands our knowledge on paradoxical sleep by deciphering at anatomical, genetic and functional levels the contribution of the SLD, considered for decades the paradoxical sleep generator. It can be functionally concluded from our results that the contingent of glutamate SLD neurons generates the paradoxical sleep-related muscle atonia and plays a limited role in paradoxical sleep generation. After genetic inactivation of glutamate, SLD signalling, paradoxical sleep is characterized by an increased muscle tone and the occurrence of abnormal excessive motor activities, resembling oneiric-like behaviours of RBD patients. In support of these physiological results, our tract-tracing data reveal that glutamate SLD neurons selectively activated during paradoxical sleep send descending projections to the medullary structures containing the GABA/glycine inhibitory premotor neurons inducing muscle atonia but not to the intralaminar thalamus neurons known to mediate the activation of the cortex during paradoxical sleep.
To determine the physiological roles that play glutamate SLD neurons in paradoxical sleep, we used AAV-shRNAs to irreversibly impair glutamate release in SLD neurons, abolishing the expression of Slc17a6/vGluT2 mRNA and the presence of the protein in synaptic terminals. This method allows one to selectively inactivate glutamate neurons and not other types of SLD neurons, such as GABAergic and cholinergic neurons, in contrast to previously used cytotoxic lesions or local pharmacology (Sastre and Jouvet, 1979; Boissard et al., 2002; Lu et al., 2006) . Further, the molecular tools used obviate the need for transgenic mice (Krenzer et al., 2011) and can be applied in the rat, a species in which the anatomo-functional delimitation of the SLD has been finely decrypted (Maloney et al., 2000; Boissard et al., 2002 Boissard et al., , 2003 Lu et al., 2006; Clement et al., 2011; Boucetta et al., 2014) .
Experimental rats depicted during paradoxical sleep aberrant motor events absent in control animals, whereas these movements never occurred during slow-wave sleep and motor behaviour remained normal during waking. Similar motor manifestations likely corresponding to oneiric behaviours have been reported in transgenic vGlut2 flox/flox mice after ablation of glutamate SLD signalling (Krenzer et al., 2011) and in cats and rats with a lesion of SLD area (Sastre et al., 1981; Lu et al., 2006) . However, in contrast to our work, the objective quantification of the muscle tone alterations and of the abnormal movements occurring during paradoxical sleep in experimental versus control animals were lacking in these previous studies. To address this, we developed and validated two complementary off-line analysis methods. First we considered nuchal EMG signal to compute the variation of muscle tone across the sleep-waking cycle. Second, we used video recordings to calculate an actimetric index of the rat's whole body reflecting every motor activity experienced during each paradoxical sleep episode. Taking advantage of these new tools, we were able to draw, for the first time, a precise paradoxical sleep-occurring behavioural phenotype in response to the genetic inactivation of glutamate transmission in the rat SLD neurons. Further, our results clearly show that glutamate SLD neurons generate the muscle atonia during paradoxical sleep.
Previous studies have shown that the electrocoagulation of the SLD in the cat or its neurochemical lesion with ibotenic acid in the rat reduced daily paradoxical sleep quantities to 40% of control levels by shortening individual bouts (Sastre et al., 1981; Lu et al., 2006) . Here we show that the genetic inactivation of glutamate SLD neurons reduces by 33% the daily paradoxical sleep amounts due to a combined decrease in the number and duration of episodes. Comparable results were reported in transgenic vGlut2 flox/flox mice with a bilateral injection of cre recombinase-expressing AAVs into the SLD and adjacent laterodorsal tegmentum to similarly eliminate local glutamate signalling (Krenzer et al., 2011) . Altogether, these data indicate that the glutamate SLD neurons are involved but not necessary for paradoxical sleep generation and EEG activation. This breaks the commonly accepted role of SLD neurons in paradoxical sleep generation, by means of simultaneous EEG activation through their ascending projections to intralaminar thalamus and a loss of muscle tone via their descending inputs to GABA/glycine premotor neurons in the gigantocellular reticular nucleus Peever et al., 2014) . To provide an anatomical substratum of the present physiological data, we examined how SLD neurons interact with both intralaminar thalamus and gigantocellular reticular nucleus. We did not find any SLD neurons sending collaterals to both nuclei simultaneously. SLD neurons with ascending projections to the intralaminar thalamus do not express c-Fos during paradoxical sleep hypersomnia, in contrast to those projecting to the gigantocellular reticular nucleus, indicating the existence of two types of SLD neurons. We previously showed in rats that 84% of the c-Fos + neurons in SLD after paradoxical sleep hypersomnia express vGlut2 (Clement et al., 2011) . Further, most of the PS-on neurons recorded in the SLD were histochemically identified as glutamate in nature by combining juxtacellular recordings and double labelling in naturally sleeping-waking, head-fixed rats (Boucetta et al., 2014) . There is therefore no doubt that SLD descending neurons are glutamate, active during paradoxical sleep and functionally responsible for inducing muscle atonia during paradoxical sleep. Our results also suggest their contribution to the fine-tuning of paradoxical sleep regulation. One possibility to be explored is that the SLD contains two subpopulations of glutamate PS-on neurons, one group with descending projections, the other group that may innervate areas critically involved in paradoxical sleep. This is the case for the posterior hypothalamus and the ventrolateral part of the periaqueductal grey as supported by previous anterograde tract-tracing in rats (Boissard et al., 2002) . Moreover, both structures are interconnected, contain different populations of PS-on neurons and functionally control paradoxical sleep genesis (Verret et al., 2006; Sapin et al., 2009; Clement et al., 2012; Luppi et al., 2014) . It is therefore likely that the removal in both areas of glutamate inputs from SLD in experimental rats may slightly unbalance this complex network with a limited deficit in paradoxical sleep amounts as a result.
The role in paradoxical sleep and the neurochemical nature of the SLD ascending projecting neurons to the intralaminar thalamus remain unclear. They could be GABA in nature since they are indeed present in SLD but do not express c-Fos after paradoxical sleep hypersomnia (Verret et al., 2006; Sapin et al., 2009) . The selective inactivation of GABA neurotransmission in SLD neurons of the transgenic Vgat flox/flox mice by local injection of AAVcre did not result in any changes in paradoxical sleep suggesting that they do not play a role in paradoxical sleep (Krenzer et al., 2011) . Here we also found that almost a quarter of SLD neurons projecting to intralaminar thalamus are cholinergic in nature in lines with previous studies showing that cholinergic neurons in the dorsal pontine tegmentum including SLD project to the intralaminar thalamus (Woolf and Butcher, 1986; Hallanger et al., 1987; Semba et al., 1990) . Pontine cholinergic neurons display a slow and tonic firing during both waking and paradoxical sleep and are nearly silent during slow-wave sleep (Boucetta et al., 2014) , suggesting that ascending SLD neurons belong to a larger group of pontine cholinergic cells with a promoting role in cortical activation during waking and paradoxical sleep Brown et al., 2012) .
The effects on muscle and behavioural activity we observed and quantified when inactivating glutamate SLD neurons in rats recapitulate quite exactly the pathological profile of RBD patients. The inactivation of other structures connected to SLD as inhibitory gigantocellular reticular nucleus neurons or the central nucleus of amygdala likely involved in emotional content of dreams (Zhang et al., 2012; Boucetta et al., 2016) are needed to determine their potential contribution to muscle atonia during paradoxical sleep and RBD and thus to validate parallel animal models of RBD. The present preclinical model, as RBD patients, suffers loss of normal muscle paralysis during paradoxical sleep which results in abnormal and forceful dream enactments (Schenck et al., 1986) . As in humans, lack of muscle atonia is heterogeneous, quite variable between individuals and paradoxical sleep bouts. Moreover, RBD rats and humans never stand up during motor-enactment, and eyes stay closed. These symptomatic similarities in patients and rats suggest that damage to the SLD neurons may underlie this human disorder. Functional neuroimaging and postmortem brain studies reported the presence of Lewy bodies, neuronal loss, depigmentation and/or gliosis within the coeruleus/subcoeruleus complex that broadly includes the SLD in idiopathic RBD patients (Schenck et al., 1996; Boeve et al., 2007; Arnulf, 2012; Boeve, 2013; Iranzo et al., 2013) , and neuronal loss strongly correlates with the severity of the motor symptoms (Garcia-Lorenzo et al., 2013; Ehrminger et al., 2016) . Around 80% of patients suffering idiopathic RBD later develop a synucleinopathy such as Parkinson's disease (Arnulf, 2012; Howell and Schenck, 2015) . Hence, idiopathic RBD is to date considered the best prodromal marker of such pathologies (Iranzo et al., 2016) . Data harvested so far in RBD patients and in our rat model strongly indicate that glutamate SLD neurons are required for the generation of muscle atonia during paradoxical sleep and play a limited role in the state of paradoxical sleep per se. These neurons may be initially targeted by -synuclein-dependent pathological processes leading to their degeneration and/or malfunctioning in RBD patients, anticipating for years the diagnosis of synucleinopathies such as Parkinson's disease. As RBD patients do not show a decrease in paradoxical sleep quantities, we propose that only descending glutamate SLD neurons responsible for muscle atonia are targeted. Determining why and how the population of descending glutamate SLD neurons is selectively vulnerable is a challenging question of major scientific and clinical relevance that must be answered for a better understanding of RBD aetiology and the mechanisms responsible for its progressive conversion over years to synucleinopathies. Our convenient, stable (for weeks) and reproducible genetic rat model that mimics faithfully RBD motor symptoms offers an ideal way to develop new therapeutic strategies.
